STP938: A phase 1/2 study of STP938 for adults with relapsed or refractory B-cell and T-cell lymphomas
Trial… which has returned (relapsed) or not responded to (refractory) two previous treatments may be eligible for this … back (relapsed) or not responded to previous treatment (refractory lymphoma). You can share the following … A phase 1/2 study of STP938 for adults with relapsed or refractory B-cell and T-cell lymphomas …